Hospitals reorder syringes, sensors, and implants whether the economy booms or stalls, and three device makers turn that habit into payouts that grow every year. Only one has a streak long enough to outlast…
Microchip beat its own forecast, yet the stock still got hammered. The CEO says AI buyers swept through supplier factories and shoved everyone else aside, and one fix could take six months. Is this…
Three rulebooks ask three very different questions about dividends, and one of them quietly lets in stocks whose yields are high because their prices collapsed. Which screen fits your retirement paycheck, and which one…
OpenAI got its money, but not on the terms it wanted, and the gap between its growth story and investor appetite is landing on two giants. One faces a bookkeeping hit, the other a…
Your employer chose your HSA provider, but monthly fees and a thin fund menu might be quietly draining your balance. One IRS-recognized move lets you escape them without giving up the payroll tax break,…
Bond coupons never grow, but these four payers just handed shareholders a raise. One has a cash-rich balance sheet, one faces a $49 billion gamble, one is heading for a breakup, and one has…
Traders keep chasing a five-figure Ethereum price while ETF money drains out and a delayed upgrade clouds the road ahead. Which scenarios could turn a $1,000 bet into a windfall, and which ones leave…
A piece of junk mail led a small feta maker to a shuttered factory with peeling paint and dripping water. What he did with that building, and a handful of former Kraft workers, set…
Sentiment improved for almost everyone except the households holding the most stock, and a survey that closed days before a brutal selloff may already be out of date. What do those wealthy investors see…